Ligand validation:6LYO

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LYO_EDO_A_1340	38%	86%	0.129	0.83	0.4	0.32	-	-	1	0	100%	1
6LYO_EDO_A_1338	25%	67%	0.292	0.929	0.29	0.96	-	-	0	0	100%	1
6JT7_EDO_A_1507	88%	75%	0.091	0.966	0.5	0.49	-	-	0	0	100%	1
6LYM_EDO_A_1324	77%	70%	0.128	0.967	0.42	0.72	-	-	1	0	100%	1
6LYK_EDO_A_1605	75%	66%	0.098	0.931	0.76	0.55	-	-	0	0	100%	1
6JT8_EDO_A_1311	49%	71%	0.176	0.925	0.37	0.72	-	-	0	0	100%	1
6JTA_EDO_A_1319	49%	32%	0.166	0.913	0.76	1.91	-	1	6	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_F_193	100%	76%	0.023	0.995	0.41	0.53	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.